Code: MTA6482 | Publication Date: Jul 2025 |
As the market is driven by rising cancer incidence, particularly breast, ovarian, and lung cancers which promotes the wider adoption of chemotherapy regimens. The focus of government is increasing on the oncology care, supported by improved screening programs and health insurance coverage, which further increase the access to treatment.
Furthermore, the competitive edge of India in generic drug manufacturing and large-scale API production is ensuring the availability of cost-effective paclitaxel formulations. The market is also observing the emergence of innovative delivery methods, such as nanoparticle and liposomal formulations, which are playing their role in improving the drug efficacy and tolerability, further fuelling the demand.
Company Name | Dr. Reddyâs Laboratories Ltd. |
Establishment Year | 1984 |
Headquarters | Hyderabad, Telangana |
Official Website | Click Here |
Dr. Reddyâs is a global pharma player producing paclitaxel injection and other oncology formulations. The company exports to over 50 countries and emphasizes innovation and biosimilars in its oncology portfolio.
Company Name | Intas Pharmaceuticals Ltd. |
Establishment Year | 1984 |
Headquarters | Ahmedabad, Gujarat |
Official Website | Click Here |
Intas is a leading manufacturer and exporter of oncology drugs including paclitaxel injection. The company has a strong presence in regulated markets and offers both branded and generic formulations.
Company Name | Fresenius Kabi Oncology Ltd. |
Establishment Year | 2003 |
Headquarters | Gurgaon, Haryana |
Official Website | Click Here |
Fresenius Kabi, a global healthcare company, manufactures oncology injectables in India including paclitaxel. It supplies to hospitals and cancer institutions across various global regions.
Company Name | Alkem Laboratories Ltd. |
Establishment Year | 1973 |
Headquarters | Mumbai, Maharashtra |
Official Website | Click Here |
Alkem produces paclitaxel injection as part of its oncology division. The company operates several USFDA-approved facilities and has a growing presence in domestic and export oncology markets.
Company Name | Emcure Pharmaceuticals Ltd. |
Establishment Year | 1981 |
Headquarters | Pune, Maharashtra |
Official Website | Click Here |
Emcure manufactures a wide range of injectable oncology drugs including paclitaxel. It is active in both domestic and international cancer care markets with a focus on innovative formulations.
Company Name | Natco Pharma Ltd. |
Establishment Year | 1981 |
Headquarters | Hyderabad, Telangana |
Official Website | Click Here |
Natco Pharma manufactures a range of oncology products including paclitaxel injection. It is known for its focus on affordability and domestic production of niche cancer therapies.
Company Name | Sun Pharmaceutical Industries Ltd. |
Establishment Year | 1983 |
Headquarters | Mumbai, Maharashtra |
Official Website | Click Here |
Sun Pharma is Indiaâs largest pharmaceutical company and a major manufacturer of paclitaxel injection. It supplies to hospitals and cancer care centers across India and multiple regulated markets.
Company Name | Biocon Ltd. |
Establishment Year | 1978 |
Headquarters | Bangalore, Karnataka |
Official Website | Click Here |
Biocon develops and manufactures oncology APIs and formulations including paclitaxel. It leverages its biologics expertise and global regulatory approvals to supply cancer treatments worldwide.
Company Name | Cipla Ltd. |
Establishment Year | 1935 |
Headquarters | Mumbai, Maharashtra |
Official Website | Click Here |
Cipla is a major Indian pharmaceutical company that manufactures paclitaxel injection under strict quality standards. It supplies oncology products globally and focuses on affordability and access to cancer care.
Company Name | Hetero Drugs Ltd. |
Establishment Year | 1993 |
Headquarters | Hyderabad, Telangana |
Official Website | - |
Hetero is known for its oncology APIs and finished formulations, including paclitaxel injection. It has a robust global presence and focuses on access to affordable chemotherapy drugs.